acc01501 |
Serine/threonine-protein kinase PRP4 homolog |
phosphorylation |
Ser520 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01502 |
SNW domain-containing protein 1 |
phosphorylation |
Ser224 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01503 |
SNW domain-containing protein 1 |
phosphorylation |
Ser232 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01504 |
Sorting nexin-1 |
phosphorylation |
Ser39 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01505 |
Nucleolar GTP-binding protein 2 |
phosphorylation |
Ser582 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01506 |
Bystin |
phosphorylation |
Ser98 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01507 |
Cyclin-dependent kinase 13 |
phosphorylation |
Ser383 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01508 |
Ribosome biogenesis protein BOP1 |
phosphorylation |
Ser127 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01509 |
Ubiquitin-associated protein 2-like |
phosphorylation |
Ser477 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01510 |
ARF GTPase-activating protein GIT2 |
phosphorylation |
Ser397 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01511 |
E3 ubiquitin-protein ligase TRIP12 |
phosphorylation |
Ser1030 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01512 |
Mediator of DNA damage checkpoint protein 1 |
phosphorylation |
Ser168 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01513 |
Chromodomain-helicase-DNA-binding protein 4 |
phosphorylation |
Ser308 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01514 |
Chromodomain-helicase-DNA-binding protein 4 |
phosphorylation |
Ser309 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01515 |
Chromodomain-helicase-DNA-binding protein 4 |
phosphorylation |
Ser310 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01516 |
Zinc finger protein 638 |
phosphorylation |
Ser510 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01517 |
Nucleolar and coiled-body phosphoprotein 1 |
phosphorylation |
Ser526 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01518 |
Nucleolar and coiled-body phosphoprotein 1 |
phosphorylation |
Ser91 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01519 |
Nucleolar and coiled-body phosphoprotein 1 |
phosphorylation |
Ser538 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01520 |
BRISC complex subunit Abraxas 2 |
phosphorylation |
Ser372 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01521 |
Condensin complex subunit 1 |
phosphorylation |
Ser1367 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01522 |
Condensin complex subunit 1 |
phosphorylation |
Ser1370 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01523 |
Condensin complex subunit 1 |
phosphorylation |
Ser1371 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01524 |
Histone-lysine N-methyltransferase SETDB1 |
phosphorylation |
Ser1130 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01525 |
WD repeat-containing protein 43 |
phosphorylation |
Ser77 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01526 |
Pericentriolar material 1 protein |
phosphorylation |
Ser65 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01527 |
Zinc finger HIT domain-containing protein 3 |
phosphorylation |
Ser80 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01528 |
Probable JmjC domain-containing histone demethylation protein 2C |
phosphorylation |
Ser652 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01529 |
ELAV-like protein 1 |
phosphorylation |
Ser202 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01530 |
Coiled-coil domain-containing protein 6 |
phosphorylation |
Ser367 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01531 |
Coiled-coil domain-containing protein 6 |
phosphorylation |
Ser52 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01532 |
Serine/arginine-rich splicing factor 7 |
phosphorylation |
Ser192 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01533 |
Survival motor neuron protein |
phosphorylation |
Ser31 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01534 |
DNA-directed RNA polymerase I subunit RPA43 |
phosphorylation |
Ser316 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01535 |
Protein FAM161A |
phosphorylation |
Ser650 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01536 |
MAP7 domain-containing protein 1 |
phosphorylation |
Ser116 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01537 |
Pleckstrin homology domain-containing family G member 6 |
phosphorylation |
Ser711 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01538 |
Pleckstrin homology domain-containing family G member 6 |
phosphorylation |
Ser712 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01539 |
AT-rich interactive domain-containing protein 4B |
phosphorylation |
Ser778 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01540 |
Rho GTPase-activating protein 29 |
phosphorylation |
Ser913 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01541 |
Rho GTPase-activating protein 29 |
phosphorylation |
Ser543 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01542 |
Protein FAM133B |
phosphorylation |
Ser152 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01543 |
Serine/threonine-protein phosphatase 6 regulatory subunit 3 |
phosphorylation |
Ser617 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01544 |
Protein PRRC2B |
phosphorylation |
Ser226 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01545 |
Centrosomal protein of 170 kDa |
phosphorylation |
Ser446 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01546 |
Centrosomal protein of 170 kDa |
phosphorylation |
Ser359 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01547 |
FK506-binding protein 15 |
phosphorylation |
Ser1114 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01548 |
Zinc finger CCCH domain-containing protein 13 |
phosphorylation |
Ser265 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01549 |
Zinc finger CCCH domain-containing protein 13 |
phosphorylation |
Ser207 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01550 |
Zinc finger CCCH domain-containing protein 13 |
phosphorylation |
Ser209 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|